These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 578067

  • 1. [Significance of the inhibitors in disseminated intravascular coagulation syndrome and relationship among antithrombin III, platelet factor 4 and heparin (author's transl)].
    Sakuragawa N, Takahashi K, Hoshiyama M, Matsuoka M.
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):218-26. PubMed ID: 578067
    [No Abstract] [Full Text] [Related]

  • 2. [Levels of beta-thromboglobulin and platelet factor 4 in various diseases (author's transl)].
    Matsuda T, Seki T, Ogawara M, Miura R, Yokouchi M, Murakami M.
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):871-8. PubMed ID: 6165213
    [No Abstract] [Full Text] [Related]

  • 3. [Plasma levels of beta-thromboglobulin and platelet factor 4 in clinical conditions (author's transl)].
    Motomiya T, Yahara Y, Onozawa Y, Watanabe C, Tomura S, Sano T, Yamazaki H.
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):864-70. PubMed ID: 6165212
    [No Abstract] [Full Text] [Related]

  • 4. [Studies on plasma platelet factor 4 (PF4). Part 2: The role of PF4 in experimental animals with disseminated intravascular coagulation (DIC) (author's transl)].
    Hoshiyama M, Sakuragawa N, Koike K, Zimbo C, Takahashi K.
    Rinsho Ketsueki; 1977 Jun; 18(6):807-13. PubMed ID: 916209
    [No Abstract] [Full Text] [Related]

  • 5. [Decreased endothelial antithrombogenic activity in disseminated intravascular coagulation].
    Tsukasato T, Maruyama Y, Maruyama I.
    Rinsho Ketsueki; 1987 Dec; 28(12):2110-6. PubMed ID: 2968472
    [No Abstract] [Full Text] [Related]

  • 6. [Heparin and antiheparin in childhood. 2. Clinical relevance of the phenomenon of heparin resistance].
    Domula M, Weissbach G.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 Dec; 109(6):878-94. PubMed ID: 6187641
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Disseminated intravascular coagulation (DIC); findings in 40 patients (author's transl)].
    Ichinose A, Maruyama I, Imaguma M, Synmyozu K, Igata A.
    Nihon Naika Gakkai Zasshi; 1981 Nov 10; 70(11):1531-6. PubMed ID: 6801163
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C, Páramo JA, Rocha E.
    Sangre (Barc); 1992 Feb 10; 37(1):5-10. PubMed ID: 1585238
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Minimal heparin cofactor activity in disseminated intravascular coagulation and cirrhosis.
    Braunstein KM, Eurenius K.
    Am J Clin Pathol; 1976 Sep 10; 66(3):488-94. PubMed ID: 60879
    [Abstract] [Full Text] [Related]

  • 14. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
    Takahashi K.
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct 10; 43(5):889-97. PubMed ID: 6940410
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human antithrombin concentrates and experimental disseminated intravascular coagulation.
    Mammen EF, Miyakawa T, Phillips TF, Assarian GS, Brown JM, Murano G.
    Semin Thromb Hemost; 1985 Oct 10; 11(4):373-83. PubMed ID: 4071063
    [Abstract] [Full Text] [Related]

  • 17. Antithrombin III(AT-III) as a diagnostic aid in disseminated intravascular coagulation.
    Bick RL, Dukes ML, Wilson WL, Fekete LF.
    Thromb Res; 1977 May 10; 10(5):721-9. PubMed ID: 882959
    [No Abstract] [Full Text] [Related]

  • 18. [Assay for activity of heparin-antithrombin III complex during treatment of DIC with heparin and its clinical significance].
    Tomihara T, Shimazu C, Yasuda K, Kazama M, Abe T.
    Rinsho Byori; 1986 Feb 10; 34(2):179-84. PubMed ID: 3702087
    [No Abstract] [Full Text] [Related]

  • 19. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
    Matsuo T, Matsuo M, Sugimoto T, Wanaka K.
    Pathophysiol Haemost Thromb; 2007 Feb 10; 36(6):305-10. PubMed ID: 20224256
    [Abstract] [Full Text] [Related]

  • 20. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH, Duckert F.
    Thromb Haemost; 1984 Oct 31; 52(2):112-6. PubMed ID: 6395434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.